Fraser McCullum

Innovation and the Future of Pharmacovigilance

Send us a text

Feeling intimidated by the thought of AI transforming the world of pharmacovigilance? Join us as we sit down with Fraser McCullum, founder of Imagine Pharmacovigilance Limited, who has spent over 20 years navigating the dynamic landscape of this industry. From his time as a bench scientist to establishing his own company, Fraser offers an insightful perspective on case processing to signal detection, and the future of risk management in pharmacovigilance.
Our conversation also delves into the feared impact of AI on the conservative PV industry. Fraser clears the air on some widespread misconceptions and provides reassurances about the supposed threat of job loss due to AI. We also explore the increasing role of regulatory oversight in the age of Software as a Service (SaaS), and discuss how pharma companies must adapt to this new reality.
We wrap up with an in-depth discussion on the future of pharmaceutical safety – from nuanced differences in ingestion methods to the rise in stimulated reporting due to Covid-19. Fraser underscores the critical necessity for collaboration within PV, the pitfalls of generic solutions, and the delicate balance of prudent spending and innovative problem-solving. Don't miss this opportunity to tap into Fraser’s vast knowledge and insights - perfect for anyone involved or interested in the world of pharmacovigilance.

Bab

1. Fraser McCullum (00:00:00)

2. Exploring Pharmacovigilance and Risk Management (00:00:15)

3. AI's Impact on a PV's Department Evolution (00:13:27)

4. Regulatory Oversight of Software Providers (00:28:37)

5. The Future of Pharmaceutical Safety (00:33:25)

6. The Importance of Collaboration in PV (00:44:29)